TranslationBlocker Human mTOR siRNA – DISCONTINUED

$ 248.00$ 368.00

Human mTOR siRNA Translation Blocker™ Duplex

SKU: QX50-2nmol Categories: , Tag:
 PDF Datasheet

DISCONTINUED: Human mTOR TranslationBlocker™ siRNA Duplex Product Attributes

Blocks transcription and translation of mTOR from: Human.
May also react with mTOR based upon sequence homology and clone specific publications.
Type of RNAi: siRNA.
siRNA target sequence: NM_004958.
Samples and cell lines tested: U87MG Human Glioblastoma Cells.
Buffer and Stabilizer: Lyophilized. See datasheet for resuspension instructions and buffer information.
Concentration of Anti-Human mTOR: Lyophilized
SiRNA Purification Method:RPC/HPLC
Storage Conditions: Store Lyophilized siRNA duplex at 4C. Reconsituted product may be stored at -20C for up to 1 month.

mTOR Knockdown Protocol:

    1. Starting with cultured cells in growth media seed plates with cells and incubated at 37°C. For instance, seed 12 well plates with 5×104 cells in growth media and incubate at 37°C overnight before starting transfections. Transfection reagents may specify the desired level of confluence to look for prior to starting transfections.
    2. The above data was generated with Oligofectamine as a transfection agent in accordance with manufacturer’s instructions. Prepare transfection reagent in serum-free growth medium such as serum-free RPMI. Allow to come to room temperature. </ li>
    3. Dilute siRNA to working concentration in serum-free growth media. For Oligofectamine or similar transfections into 6 well plates, we recommend starting siRNA dose optimization at approximately 100 pmol siRNA duplex.Optimal dilution should be experimentally determined.
    4. Combine diluted siRNA and transfection reagent. Ratio of transfection reagent to siRNA should be optimized. Equivalent volumes of prepared Oligofectamine or other transfection reagent and diluted siRNA should be combined and incubated at room temperature for 20 minutes with gentle mixing.
    5. Add prepared siRNA solution to cells. For 12 well plates this will entail adding the solution to cells in approximately 1.1 ml serum-free medium. Optionally, FITC labeled control siRNA (Product Number QC-1F) or positive control siRNA (Beta-Actin; Product Number QC-2) may be used to assess transfection efficiency.
    6. Incubate for several hours in serum free media. Generally, a 4 hour initial transfection incubation is recommended.
    7. Add serum containing media to culture without a media change if longer incubation times are required. Generally 1-2 fold of the original volume of siRNA containing serum-free media is added to restore nutrient levels in media. Alternatively, the media may be directly supplemented with serum such as 10% FBS.
    8. Incubate and assay several hours after transfection. Optimal knockdown time should also be experimentally determined. Optionally, a second transfection can be performed 24 hours after the first transfection to enhance knockdown. mTor knockdown at the protein level was measured at 72 hours post transfection via Western Blot.

mTOR General Information

Gene Name: MTOR
Entrez Gene ID: 2475
NCBI Ref Seq Accession Number: NP_004949
Uniprot ID:
mTOR Molecular Weight:
Alternate Names: SKS, FRAP1, RAFT1, FRAP, RAPT1, FRAP2, Serine/threonine-protein kinase mTor, mechanistic target of rapamycin

Limitations and Warranty

This product is for Research Use Only. This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.



Product Type



There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

TranslationBlocker Human mTOR siRNA - DISCONTINUED